Jazz Pharmaceuticals PLC (HAM:J7Z)
€ 209.5 +9.8 (+4.91%) Market Cap: 13.30 Bil Enterprise Value: 15.53 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 73/100

Jazz Pharmaceuticals PLC at TD Cowen Oncology Innovation Summit (Virtual) Transcript

May 27, 2026 / 06:00 PM GMT
Release Date Price: €204 (-1.97%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

JAZZ.OQ - Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC at TD Cowen Oncology Innovation Summit (Virtual)
May 27, 2026 / 06:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi, everyone. Good afternoon again, and thank you for joining us at the 2026 TD Cowan Biotech Oncology Innovation Summit. I'm Joe Thome, one of the biotech analysts here on the team at TD Cowan. It's my pleasure to have with me today two members of the Jazz Pharmaceuticals team. We have EVP Global Head of R&D and CMO Rob Ianone. And we have the Head of Investor Relations, John Blue. So thanks, guys, for joining us today. Maybe to kick things off.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
And Joe, just very quickly, a little housekeeping.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot